Arcutis Biotherapeutics I... (ARQT)
13.67
0.39 (2.94%)
At close: Jan 15, 2025, 9:33 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 59.61M | 3.69M | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 4.99M | 754.00K | 763.00K | 455.00K | 195.00K | n/a | n/a |
| Gross Profit | 54.62M | 2.93M | -763.00K | -455.00K | -195.00K | n/a | n/a |
| Operating Income | -241.10M | -301.63M | -206.53M | -136.65M | -43.13M | -19.73M | -4.11M |
| Interest Income | n/a | 9.83M | 173.00K | 967.00K | 1.14M | n/a | n/a |
| Pretax Income | -259.03M | -311.46M | -206.36M | -135.68M | -42.00M | -19.25M | -4.98M |
| Net Income | -262.14M | -321.29M | -205.90M | -135.68M | -42.00M | -19.25M | -4.98M |
| Selling & General & Admin | 185.15M | 122.12M | 60.97M | 21.34M | 6.61M | 1.79M | 695.00K |
| Research & Development | 110.58M | 182.44M | 145.56M | 115.31M | 36.52M | 17.94M | 3.41M |
| Other Expenses | n/a | 5.82M | 173.00K | 967.00K | 1.14M | 480.00K | -872.00K |
| Operating Expenses | 295.72M | 304.56M | 206.53M | 136.65M | 43.13M | 19.73M | 4.11M |
| Interest Expense | 29.71M | 15.65M | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 300.71M | 305.31M | 206.53M | 136.65M | 43.13M | 19.73M | 4.11M |
| Income Tax | 3.11M | 9.83M | -454.00K | -84.30K | 23.14K | -480.00K | -4.11M |
| Shares Outstanding (Basic) | 69.31M | 55.03M | 49.41M | 35.67M | 38.09M | 36.24M | 36.24M |
| Shares Outstanding (Diluted) | 69.31M | 55.03M | 49.41M | 35.67M | 38.09M | 36.24M | 36.24M |
| EPS (Basic) | -3.78 | -5.84 | -4.17 | -3.8 | -1.1 | -0.53 | -0.14 |
| EPS (Diluted) | -3.78 | -5.84 | -4.17 | -3.8 | -1.1 | -0.53 | -0.14 |
| EBITDA | -227.43M | -294.55M | -205.59M | -135.22M | -41.80M | 480.00K | -872.00K |
| Depreciation & Amortization | 1.88M | 1.25M | 763.00K | 455.00K | 195.00K | 19.73M | 4.11M |